Implementation of PIC / S GMP, Taiwan Pharmaceutical Companies’ Competitive Strategy Strive for International Business

• Main Authors: Fang, Wan-Ju, 房婉如
• Other Authors: Ching Horng
• Format: Others
• Language: zh-TW
• Published: 2015
• Online Access: http://ndltd.ncl.edu.tw/handle/12727187006666782733

碩士 === 國立中正大學 === 企業管理研究所 === 103 === The pharmaceutical industry is related to human life and health. With life is more affluent and science is more developed, the drug quality management become more and more stringent for every country. In 2015, Taiwan implements PIC / S GMP in full. Taiwan pharmaceutical industry follows international standards entering a new milestone. However, the pharmaceutical companies make huge capital investment to upgrade facility, but the profit decline in original domestic market because the health insurance payments decrease, the companies must involve in new markets more actively. Therefore, Taiwan pharmaceutical companies must follow the Government policy, international trends and combine their own advantages to strength the cooperation with international relationship and find a new direction. This study is to understand after the implementation of PIC / S GMP, the competitive strategy and effectiveness of Taiwan pharmaceutical companies to enter the international market and take orders, but also as learn to other companies for entering the international market. After interviewing with the respondents, this study summarize in the following conclusions. 1. PIC / S GMP is to enhance the competitive advantage for international orders. 2. Implementing PIC / S GMP could reduce the technical trading barriers. 3. Product differentiation is conducive to compete in the international market. 4. The stronger cross-functional integration helps to get the international orders. 5. Abundant network is gotten more opportunity to get international orders. 6. Cooperation with international pharmaceutical companies helps to improve the international competitiveness of its own Although the Government has expanded international medical cooperation actively, but it limited by political, national sovereignty, the effect is not clear at present. Taiwanese companies still need to enhance their own strength, training personnel with an international perspective and increasing acuity on the international market, in order to fight for international orders successfully.